Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pig for Live is a Belgian biotechnology company specializing in the production of high-quality, pathogen-free porcine cells and tissues for human xenotransplantation. Established as a spin-off from the EU-funded XENOISLETS project, the company operates a state-of-the-art Designated Pathogen Free (DPF) facility in Marche-en-Famenne. Its primary focus is the development of transgenic pig lines to provide pancreatic islets for the treatment of Type 1 and Type 2 diabetes. By ensuring strict biosecurity and regulatory compliance, Pig for Live aims to address the global shortage of human donor organs through safe and scalable animal-derived therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pig for Live.